# Performance Food Group Co: financial statements, quarterly

PFGC · NYSE · CIK 1618673 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jun 27

Pages: [Overview](/companies/pfgc.md) · [Financials](/companies/pfgc/financials.md) · [Filings](/companies/pfgc/filings.md) · [Insiders](/companies/pfgc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfgc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q4 FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q4 FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | Q4 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [14.9](/filings/0000950170-24-122325.md) | [14.3](/filings/0000950170-25-014484.md) | [13.9](/filings/0000950170-25-065695.md) | [15.2 d](/filings/0001193125-26-346886.md) | [15.4](/filings/0001193125-25-266975.md) | [15.6](/filings/0001193125-26-037614.md) | [15.3](/filings/0001193125-26-209011.md) | [16.9 d](/filings/0001193125-26-346886.md) | [17.1](/filings/0001193125-25-266975.md) | [16.4](/filings/0001193125-26-037614.md) | [16.3](/filings/0001193125-26-209011.md) | [18.0 d](/filings/0001193125-26-346886.md) |
| Cost of revenue | $bn | [13.3](/filings/0000950170-24-122325.md) | [12.7](/filings/0000950170-25-014484.md) | [12.3](/filings/0000950170-25-065695.md) | [13.4 d](/filings/0001193125-26-346886.md) | [13.7](/filings/0001193125-25-266975.md) | [13.8](/filings/0001193125-26-037614.md) | [13.5](/filings/0001193125-26-209011.md) | [14.9 d](/filings/0001193125-26-346886.md) | [15.1](/filings/0001193125-25-266975.md) | [14.5](/filings/0001193125-26-037614.md) | [14.4](/filings/0001193125-26-209011.md) | [15.9 d](/filings/0001193125-26-346886.md) |
| Gross profit | $bn | [1.7](/filings/0000950170-24-122325.md) | [1.6](/filings/0000950170-25-014484.md) | [1.6](/filings/0000950170-25-065695.md) | [1.7 d](/filings/0001193125-26-346886.md) | [1.8](/filings/0001193125-25-266975.md) | [1.8](/filings/0001193125-26-037614.md) | [1.8](/filings/0001193125-26-209011.md) | [2.0 d](/filings/0001193125-26-346886.md) | [2.0](/filings/0001193125-25-266975.md) | [2.0](/filings/0001193125-26-037614.md) | [1.9](/filings/0001193125-26-209011.md) | [2.2 d](/filings/0001193125-26-346886.md) |
| Operating income | $bn | [0.2](/filings/0000950170-24-122325.md) | [0.2](/filings/0000950170-25-014484.md) | [0.2](/filings/0000950170-25-065695.md) | [0.3 d](/filings/0001193125-26-346886.md) | [0.2](/filings/0001193125-25-266975.md) | [0.2](/filings/0001193125-26-037614.md) | [0.2](/filings/0001193125-26-209011.md) | [0.3 d](/filings/0001193125-26-346886.md) | [0.2](/filings/0001193125-25-266975.md) | [0.2](/filings/0001193125-26-037614.md) | [0.1](/filings/0001193125-26-209011.md) | [0.3 d](/filings/0001193125-26-346886.md) |
| Interest expense | $bn | [0.1](/filings/0000950170-24-122325.md) | [0.1](/filings/0000950170-25-014484.md) | [0.1](/filings/0000950170-25-065695.md) | [0.1 d](/filings/0001193125-26-346886.md) | [0.1](/filings/0001193125-25-266975.md) | [0.1](/filings/0001193125-26-037614.md) | [0.1](/filings/0001193125-26-209011.md) | [0.1 d](/filings/0001193125-26-346886.md) | [0.1](/filings/0001193125-25-266975.md) | [0.1](/filings/0001193125-26-037614.md) | [0.1](/filings/0001193125-26-209011.md) | [0.1 d](/filings/0001193125-26-346886.md) |
| Income tax | $bn | [0.0](/filings/0000950170-24-122325.md) | [0.0](/filings/0000950170-25-014484.md) | [0.0](/filings/0000950170-25-065695.md) | [0.1 d](/filings/0001193125-26-346886.md) | [0.0](/filings/0001193125-25-266975.md) | [0.0](/filings/0001193125-26-037614.md) | [0.0](/filings/0001193125-26-209011.md) | [0.0 d](/filings/0001193125-26-346886.md) | [0.0](/filings/0001193125-25-266975.md) | [0.0](/filings/0001193125-26-037614.md) | [0.0](/filings/0001193125-26-209011.md) | [0.1 d](/filings/0001193125-26-346886.md) |
| Net income | $bn | [0.1](/filings/0000950170-24-122325.md) | [0.1](/filings/0000950170-25-014484.md) | [0.1](/filings/0000950170-25-065695.md) | [0.2 d](/filings/0001193125-26-346886.md) | [0.1](/filings/0001193125-25-266975.md) | [0.0](/filings/0001193125-26-037614.md) | [0.1](/filings/0001193125-26-209011.md) | [0.1 d](/filings/0001193125-26-346886.md) | [0.1](/filings/0001193125-25-266975.md) | [0.1](/filings/0001193125-26-037614.md) | [0.0](/filings/0001193125-26-209011.md) | [0.2 d](/filings/0001193125-26-346886.md) |
| Diluted EPS | $ per share | [0.77](/filings/0000950170-24-122325.md) | [0.50](/filings/0000950170-25-014484.md) | [0.45](/filings/0000950170-25-065695.md) | not reported | [0.69](/filings/0001193125-25-266975.md) | [0.27](/filings/0001193125-26-037614.md) | [0.37](/filings/0001193125-26-209011.md) | not reported | [0.60](/filings/0001193125-25-266975.md) | [0.39](/filings/0001193125-26-037614.md) | [0.27](/filings/0001193125-26-209011.md) | not reported |
| Basic EPS | $ per share | [0.78](/filings/0000950170-24-122325.md) | [0.51](/filings/0000950170-25-014484.md) | [0.46](/filings/0000950170-25-065695.md) | not reported | [0.70](/filings/0001193125-25-266975.md) | [0.27](/filings/0001193125-26-037614.md) | [0.38](/filings/0001193125-26-209011.md) | not reported | [0.60](/filings/0001193125-25-266975.md) | [0.40](/filings/0001193125-26-037614.md) | [0.27](/filings/0001193125-26-209011.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0000950170-23-061166.md) | [0.0](/filings/0000950170-24-012248.md) | [0.0](/filings/0000950170-24-055773.md) | [0.0](/filings/0001618673-25-000012.md) | [0.0](/filings/0000950170-24-122325.md) | [0.0](/filings/0000950170-25-014484.md) | [0.0](/filings/0000950170-25-065695.md) | [0.1](/filings/0001193125-26-346886.md) | [0.0](/filings/0001193125-25-266975.md) | [0.0](/filings/0001193125-26-037614.md) | [0.0](/filings/0001193125-26-209011.md) | [0.1](/filings/0001193125-26-346886.md) |
| Current assets | $bn | [6.2](/filings/0000950170-23-061166.md) | [6.0](/filings/0000950170-24-012248.md) | [5.8](/filings/0000950170-24-055773.md) | [6.2](/filings/0001618673-25-000012.md) | [6.5](/filings/0000950170-24-122325.md) | [6.9](/filings/0000950170-25-014484.md) | [6.8](/filings/0000950170-25-065695.md) | [7.1](/filings/0001193125-26-346886.md) | [7.6](/filings/0001193125-25-266975.md) | [7.4](/filings/0001193125-26-037614.md) | [7.4](/filings/0001193125-26-209011.md) | [7.8](/filings/0001193125-26-346886.md) |
| Total assets | $bn | [12.9](/filings/0000950170-23-061166.md) | [12.9](/filings/0000950170-24-012248.md) | [12.9](/filings/0000950170-24-055773.md) | [13.4](/filings/0001618673-25-000012.md) | [14.4](/filings/0000950170-24-122325.md) | [17.1](/filings/0000950170-25-014484.md) | [17.1](/filings/0000950170-25-065695.md) | [17.9](/filings/0001193125-26-346886.md) | [18.4](/filings/0001193125-25-266975.md) | [18.2](/filings/0001193125-26-037614.md) | [18.4](/filings/0001193125-26-209011.md) | [18.8](/filings/0001193125-26-346886.md) |
| Current liabilities | $bn | [3.5](/filings/0000950170-23-061166.md) | [3.5](/filings/0000950170-24-012248.md) | [3.5](/filings/0000950170-24-055773.md) | [3.8](/filings/0001618673-25-000012.md) | [3.8](/filings/0000950170-24-122325.md) | [4.1](/filings/0000950170-25-014484.md) | [4.2](/filings/0000950170-25-065695.md) | [4.5](/filings/0001193125-26-346886.md) | [4.6](/filings/0001193125-25-266975.md) | [4.6](/filings/0001193125-26-037614.md) | [4.9](/filings/0001193125-26-209011.md) | [5.2](/filings/0001193125-26-346886.md) |
| Total liabilities | $bn | [9.1](/filings/0000950170-23-061166.md) | [9.1](/filings/0000950170-24-012248.md) | [8.9](/filings/0000950170-24-055773.md) | [9.3](/filings/0001618673-25-000012.md) | [10.2](/filings/0000950170-24-122325.md) | [12.8](/filings/0000950170-25-014484.md) | [12.8](/filings/0000950170-25-065695.md) | [13.4](/filings/0001193125-26-346886.md) | [13.8](/filings/0001193125-25-266975.md) | [13.5](/filings/0001193125-26-037614.md) | [13.7](/filings/0001193125-26-209011.md) | [13.9](/filings/0001193125-26-346886.md) |
| Long-term debt | $bn | [3.7](/filings/0000950170-23-061166.md) | [3.5](/filings/0000950170-24-012248.md) | [3.2](/filings/0000950170-24-055773.md) | [3.2](/filings/0001618673-25-000012.md) | [3.9](/filings/0000950170-24-122325.md) | [5.7](/filings/0000950170-25-014484.md) | [5.4](/filings/0000950170-25-065695.md) | [5.4](/filings/0001193125-26-346886.md) | [5.6](/filings/0001193125-25-266975.md) | [5.3](/filings/0001193125-26-037614.md) | [5.1](/filings/0001193125-26-209011.md) | [5.0](/filings/0001193125-26-346886.md) |
| Current portion of debt | $bn | [0.0](/filings/0000950170-23-061166.md) | [0.0](/filings/0000950170-24-012248.md) | [0.0](/filings/0000950170-24-055773.md) | [0.0](/filings/0001618673-25-000012.md) | [0.0](/filings/0000950170-24-122325.md) | [0.0](/filings/0000950170-25-014484.md) | [0.0](/filings/0000950170-25-065695.md) | [0.0](/filings/0001193125-26-346886.md) | [0.0](/filings/0001193125-25-266975.md) | [0.0](/filings/0001193125-26-037614.md) | [0.0](/filings/0001193125-26-209011.md) | [0.0](/filings/0001193125-26-346886.md) |
| Shareholders' equity | $bn | [3.8](/filings/0000950170-25-014484.md) | [3.9](/filings/0000950170-25-065695.md) | [4.0](/filings/0000950170-25-065695.md) | [4.1](/filings/0001193125-26-346886.md) | [4.2](/filings/0001193125-26-037614.md) | [4.3](/filings/0001193125-26-209011.md) | [4.3](/filings/0001193125-26-209011.md) | [4.5](/filings/0001193125-26-346886.md) | [4.6](/filings/0001193125-26-037614.md) | [4.6](/filings/0001193125-26-209011.md) | [4.7](/filings/0001193125-26-209011.md) | [4.9](/filings/0001193125-26-346886.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q4 FY2024 (2024-06-29) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q4 FY2025 (2025-06-28) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) | Q4 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [87.1](/filings/0000950170-24-122325.md) | [467 d](/filings/0000950170-25-014484.md) | [403 d](/filings/0000950170-25-065695.md) | [206 d](/filings/0001193125-26-346886.md) | [53.5](/filings/0001193125-25-266975.md) | [326 d](/filings/0001193125-26-037614.md) | [448 d](/filings/0001193125-26-209011.md) | [383 d](/filings/0001193125-26-346886.md) | [(145)](/filings/0001193125-25-266975.md) | [601 d](/filings/0001193125-26-037614.md) | [616 d](/filings/0001193125-26-209011.md) | [342 d](/filings/0001193125-26-346886.md) |
| Capital expenditure | $m | [53.2](/filings/0000950170-24-122325.md) | [93.9](/filings/0000950170-25-014484.md) | [97.3](/filings/0000950170-25-065695.md) | [151 d](/filings/0001193125-26-346886.md) | [96.5](/filings/0001193125-25-266975.md) | [107](/filings/0000950170-25-014484.md) | [129](/filings/0000950170-25-065695.md) | [173 d](/filings/0001193125-26-346886.md) | [78.9](/filings/0001193125-25-266975.md) | [113 d](/filings/0001193125-26-037614.md) | [73.6 d](/filings/0001193125-26-209011.md) | [118 d](/filings/0001193125-26-346886.md) |
| Share repurchases | $m | [28.1](/filings/0000950170-24-122325.md) | [50.0 d](/filings/0000950170-25-014484.md) | [0.0 d](/filings/0000950170-25-065695.md) | [0.0 d](/filings/0001193125-26-346886.md) | [29.2](/filings/0001193125-25-266975.md) | [4.4 d](/filings/0001193125-26-037614.md) | [10.0 d](/filings/0001193125-26-209011.md) | [14.0 d](/filings/0001193125-26-346886.md) | [0.0](/filings/0001193125-25-266975.md) | [0.0 d](/filings/0001193125-26-037614.md) | [0.9 d](/filings/0001193125-26-209011.md) | [0.6 d](/filings/0001193125-26-346886.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-01) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-04-01) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-30) | Q3 FY2024 (2024-03-30) | Q1 FY2025 (2024-09-28) | Q2 FY2025 (2024-12-28) | Q3 FY2025 (2025-03-29) | Q1 FY2026 (2025-09-27) | Q2 FY2026 (2025-12-27) | Q3 FY2026 (2026-03-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [156](/filings/0000950170-23-061166.md) | [156](/filings/0000950170-24-012248.md) | [157](/filings/0000950170-24-055773.md) | [157](/filings/0000950170-24-122325.md) | [156](/filings/0000950170-25-014484.md) | [156](/filings/0000950170-25-065695.md) | [156](/filings/0001193125-25-266975.md) | [156](/filings/0001193125-26-037614.md) | [157](/filings/0001193125-26-209011.md) | [157](/filings/0001193125-25-266975.md) | [157](/filings/0001193125-26-037614.md) | [157](/filings/0001193125-26-209011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 157,533,032 at 2026-08-05, from the cover of the [10-K filed 2026-08-12](/filings/0001193125-26-346886.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.